Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar

Table 1 Isolate reference number, source, year of isolation and resistance phenotype of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar between 2008 and 2016

Isolate reference number	Source	Year of isolation	Resistance phenotype Disk diffusion method	E-test (MICs, mg/L)
				IPM	MEM
AB 346^a	W	2013	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 285^a	PF	2013	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, SXT, CIP, MEM	> 32	> 32
AB 79^a	W	2016	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, AMK, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 116^a	W	2016	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, AMK, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 184^a	U	2016	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, CIP, MEM, NAL	> 32	> 32
AB 406^a	BAL	2016	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, AMK, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 334^a	BAL	2014	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, AMK, CIP, MEM, NAL, LVX	> 32	> 32
AB4046^a	UP	2015	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, CIP, MEM, NAL	> 32	> 32
AB 141^a	W	2016	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 006^b	RS	2015	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, CIP, MEM, NAL, LVX	> 32	> 32
AB 153^b	RS	2015	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, CIP, MEM, NAL, LVX	> 32	> 32
AB 142^b	F	2015	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, SXT, CIP, MEM, NAL, LVX	> 32	> 32
AB 187^b	RS	2015	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, TOB, CIP, MEM, NAL, LVX	> 32	> 32
AB 1784^c	BSI	2013	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, AMK, SXT, CIP, MEM, NAL, LVX	12	> 32
AB 176^d	SP	2008	TIC, TIM, PIP, TZP, CAZ, CTX, FEP, GEN, AMK, SXT, CIP, MEM, NAL, LVX	> 32	> 32

MICs minimum inhibitory concentrations, TIC ticarcillin, TIM ticarcillin-clavulanic acid, PIP piperacillin, TZP piperacillin-tazobactam, CAZ ceftazidime, CTX cefotaxime, FEP cefepime, GEN gentamicin, TOB tobramycin, AMK amikacin, CIP ciprofloxacin, MEM meropenem, IPM imipenem, NAL nalidixic acid, LVX levofloxacin, W wound, PF pleural fluid, U urine, BAL bronchoalvealar lavage fluid, UP urethral pus, SP superficial pus, RS rectal swab, F faeces, RS rectal swab, BSI blood stream infection
^aStrains isolated from biological samples collected at Institut Pasteur of Madagascar
^bStrains collected from the neonatal unit at Antananarivo military hospital
^cStrains isolated from the intensive care unit at Mahajanga Androva Hospital
^dStrains isolated from the intensive care unit at Antananarivo Joseph Ravoahangy Andrianavalona (HJRA) hospital
MICs > 8 mg/L for imipenem and meropenem were considered resistant

ISSN: 2047-2994